Septerna Inc (SEPN)

Jun 10, 2025

Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies - MSN

Jun 10, 2025

Jun 06, 2025

Nuveen Asset Management LLC Buys New Stake in Septerna, Inc. (NASDAQ:SEPN) - Defense World

Jun 06, 2025

Jun 04, 2025

Bank of America Corp DE Makes New Investment in Septerna, Inc. (NASDAQ:SEPN) - Defense World

Jun 04, 2025

Jun 02, 2025

Septerna To Present At Jefferies Conference; SEP-631 Phase 1 Trial On Track For Q3 - Nasdaq

Jun 02, 2025

Jun 02, 2025

Deutsche Bank AG Invests $239,000 in Septerna, Inc. (NASDAQ:SEPN) - Defense World

Jun 02, 2025

May 29, 2025

Septerna to Present at Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025

May 29, 2025

GPCR Pioneer Septerna Reveals Latest Drug Discovery Progress at Major Jefferies Healthcare Event - Stock Titan

May 29, 2025

May 28, 2025

Jane Street Group LLC Invests $600,000 in Septerna, Inc. (NASDAQ:SEPN) - Defense World

May 28, 2025

May 23, 2025

Analysts Think These Stocks Could More Than Double in Value - Investing.com

May 23, 2025

May 23, 2025

Analysts Think These Stocks Could More Than Double in Value - MarketBeat

May 23, 2025

May 22, 2025

Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect? - MSN

May 22, 2025

May 20, 2025

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna - MSN

May 20, 2025

May 20, 2025

Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled - MSN

May 20, 2025

May 18, 2025

Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer - The Globe and Mail

May 18, 2025

May 18, 2025

Novo Nordisk, Septerna Agree $2.2 Billion Obesity Pill Deal - MSN

May 18, 2025

May 18, 2025

Cantor Fitzgerald Remains a Buy on Septerna, Inc. (SEPN) - The Globe and Mail

May 18, 2025

May 18, 2025

Wells Fargo & Company Boosts Septerna (NASDAQ:SEPN) Price Target to $18.00 - Defense World

May 18, 2025

May 17, 2025

Septerna First Quarter 2025 Earnings: US$0.49 loss per share (vs US$6.35 loss in 1Q 2024) - simplywall.st

May 17, 2025

May 17, 2025

22,095 Shares in Septerna, Inc. (NASDAQ:SEPN) Bought by The Manufacturers Life Insurance Company - Defense World

May 17, 2025

May 17, 2025

ETFs to Capitalize on the Novo Nordisk-Septerna Deal - MSN

May 17, 2025

May 16, 2025

Novo Nordisk in pact with Septerna for oral obesity drugs - MSN

May 16, 2025

May 16, 2025

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments - MSN

May 16, 2025

May 16, 2025

Septerna: Novo's Investment In Incretin Program IntriguesOne For The Watchlist - Seeking Alpha

May 16, 2025

May 16, 2025

Where Septerna Stands With Analysts - Benzinga

May 16, 2025

May 16, 2025

Septerna: Deal With Novo Nordisk Is A Game Changer, While It Still Trades Well Below Net Cash - Seeking Alpha

May 16, 2025

May 16, 2025

Cantor Fitzgerald lifts Septerna stock to $25 target, maintains overweight By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Cantor Fitzgerald lifts Septerna stock to $25 target, maintains overweight - Investing.com

May 16, 2025

May 16, 2025

Novo Nordisk and Septerna enter $2.2bn cardiometabolic disease partnership - PMLiVE

May 16, 2025

May 16, 2025

Septerna price target raised to $18 from $11 at Wells Fargo - TipRanks

May 16, 2025

May 16, 2025

Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills - MSN

May 16, 2025

May 16, 2025

Biotech Stocks Worth Watching – May 14th - Defense World

May 16, 2025

May 16, 2025

Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results - The Manila Times

May 16, 2025

May 15, 2025

Septerna, Inc.: Strategic Partnerships and Promising Pipeline Drive Buy Rating - TipRanks

May 15, 2025

May 15, 2025

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Sapterna - MSN

May 15, 2025

May 15, 2025

Septerna reports Q1 EPS (49c), consensus (45c) - TipRanks

May 15, 2025

May 15, 2025

Novo Nordisk Invests $2.2B in Septerna’s Oral Drugs - Contract Pharma

May 15, 2025

May 15, 2025

Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk - MSN

May 15, 2025

May 15, 2025

Novo Nordisk Inks $2.2 Billion Deal with Septerna to Advance Obesity and Diabetes Treatments - MSN

May 15, 2025

May 15, 2025

Novo Nordisk, Septerna collaborate on developing GPCR therapies - World Pharmaceutical Frontiers

May 15, 2025

May 14, 2025

Novo Nordisk Partners with Septerna for New Obesity Drug Development - GuruFocus

May 14, 2025

May 14, 2025

Novo Nordisk, Septerna Ink Up To $2.2B Obesity Drug Deal - Law360

May 14, 2025

May 14, 2025

Novo Nordisk Looks To Septerna For Oral Obesity Options - insights.citeline.com

May 14, 2025

May 14, 2025

Septerna joins a $2.2B obesity deal with Novo - BioWorld MedTech

May 14, 2025

May 14, 2025

Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing - Investor's Business Daily

May 14, 2025

May 14, 2025

eToro's Nasdaq debut, Exelixis outlook, Septerna–Novo deal - Yahoo Finance

May 14, 2025

May 14, 2025

Money Movers: HIT, SEPN, ALUR, LUCY, PRSO – Biotech, Healthcare, AI & Weight Loss Innovators Lead Momentum Surge – More Stocks Inside | FinancialContent - FinancialContent

May 14, 2025